Search results
Pages
-
- Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
-
- Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data
-
- The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
-
- Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer
-
- Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma
-
- A prospective comparison of younger and older patients' preferences for breast-conserving surgery versus mastectomy in early breast cancer
-
- The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors
-
- Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer
-
- Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES
-
- Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe
-
- Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries
-
- The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study
-
- Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial